Table 4.
Univariate and multivariate analysis of factors associated with antihypertensive-related DTPs among patients at MRRH from November 2021 to January 2022.
| Independent variables | Dependent variable | COR(95% CI) | p-value | AOR(95% CI) | p-value | ||
|---|---|---|---|---|---|---|---|
| variable | Category | DTP | |||||
| No n(%) | Yes n(%) | ||||||
| 87 (38.2) |
141 (61.8) |
||||||
| Herbal medicine use | Yes | 18 (29.0) | 44 (71.0) | 1.74(0.93–3.26) | 0.085 | 1.73 (0.87–3.42) | 0.118 |
| No | 69 (47.3) | 77 (52.7) | 1 | 1 | |||
| Duration of HTN treatment | 1–5 years | 62 (39.7) | 94 (60.3) | 1 | 1 | ||
| 6–10 years | 21 (44.7) | 26 (55.3) | 0.82 (0.42–1.58) | 0.546 | 0.84 (0.41–1.71) | 0.627 | |
| > 10 years | 4 (16.0) | 21 (84.0) | 3.46 (1.13–10.57) | 0.029 | 3.22 (1.00–10.4) | 0.050 | |
| BP control | Controlled | 48 (60.8) | 31 (39.2) | 1 | 1 | ||
| Uncontrolled | 39 (26.2) | 110 (73.8) | 4.37 (2.44–7.80) | < 0.001 | 4.17 (2.33–7.45) | < 0.001 | |
| Availability of routine Laboratory test results | Yes | 29 (29.6) | 69 (70.4) | 1.92 (1.10–3.34) | 0.022 | 1.87 (1.04–3.36) | 0.036 |
| No | 58 (44.6) | 72 (55.4) | 1 | 1 | |||
AOR: adjusted odds ratio; BP, blood pressure; CI, confidence interval; COR: crude odds ratio; DTP, drug therapy problems; HTN, hypertension.